9.61
前日終値:
$9.46
開ける:
$9.49
24時間の取引高:
512.75K
Relative Volume:
0.62
時価総額:
$569.10M
収益:
$1.08B
当期純損益:
$139.50M
株価収益率:
4.0523
EPS:
2.3715
ネットキャッシュフロー:
$205.80M
1週間 パフォーマンス:
+8.22%
1か月 パフォーマンス:
+9.33%
6か月 パフォーマンス:
-30.76%
1年 パフォーマンス:
-19.31%
Embecta Corp Stock (EMBC) Company Profile
Compare EMBC vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
EMBC
Embecta Corp
|
9.61 | 560.22M | 1.08B | 139.50M | 205.80M | 2.3715 |
|
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-10 | 開始されました | Mizuho | Neutral |
| 2024-12-02 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-27 | アップグレード | BTIG Research | Neutral → Buy |
| 2023-10-20 | 開始されました | Wolfe Research | Peer Perform |
| 2023-01-06 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2022-09-08 | 開始されました | BTIG Research | Neutral |
| 2022-08-01 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-06-21 | 開始されました | BofA Securities | Underperform |
すべてを表示
Embecta Corp (EMBC) 最新ニュース
(EMBC) and the Role of Price-Sensitive Allocations - Stock Traders Daily
How The Embecta (EMBC) Investment Story Is Shifting As Fair Value And Expectations Reset - Yahoo Finance
Embecta Corp stock (US29082K1051): Why does its diabetes focus matter more for U.S. investors now? - AD HOC NEWS
Should You Investigate Embecta Corp. (NASDAQ:EMBC) At US$8.88? - Yahoo Finance
Embecta Corp stock: What investors need to know about its diabetes focus now - AD HOC NEWS
Embecta Corp. (EMBC) Stock Forecasts - Yahoo Finance
Aug Sectors: Why is Embecta Corp stock going up2026 Volume Leaders & Weekly Watchlist of Top Performers - baoquankhu1.vn
embecta Welcomes New Board Chair and Lead Independent Director - Medical Product Outsourcing
Responsive Playbooks and the EMBC Inflection - Stock Traders Daily
SG Americas Securities LLC Acquires Shares of 435,842 Embecta Corp. $EMBC - MarketBeat
EMBC SEC FilingsEmbecta Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Embecta Corp Stock: A Focused Leader in Diabetes Care with Proven Products and Strategic Independenc - AD HOC NEWS
Embecta Corp (JX7.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
JPMorgan Chase & Co. Boosts Stock Position in Embecta Corp. $EMBC - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Sees Large Increase in Short Interest - MarketBeat
Embecta Corp. Stock Plummets to New 52-Week Low of $8.47 - Markets Mojo
Market Rankings: Why is Embecta Corp stock going upShort Setup & Risk Managed Investment Entry Signals - baoquankhu1.vn
Mills & Reeve advises Owen Mumford on £150m sale to embecta Corp in New Jersey - Business Weekly
Embecta agrees to acquire Owen Mumford - MSN
Embecta Corp. Stock Plummets to New 52-Week Low of $8.68 - Markets Mojo
Vanguard reorganizes reporting; EMBC ownership listed as 0 (EMBC) - Stock Titan
Embecta (NASDAQ:EMBC) Sets New 12-Month LowTime to Sell? - MarketBeat
Understanding the Setup: (EMBC) and Scalable Risk - Stock Traders Daily
“Landmark moment” for medical device manufacturer with sale to Nasdaq-listed groupMills & Reeve advised - Insider Media Ltd
Embecta Plans Acquisition of Owen Mumford to Broaden Drug-Delivery Offerings - Bitget
Embecta to Acquire Owen Mumford to Expand Drug-Delivery Portfolio - Zacks Investment Research
Embecta to buy Owen Mumford for up to £150M - MSN
Performance Recap: Will Embecta Corp stock go up in YEAR2026 Earnings & Daily Volume Surge Signals - baoquankhu1.vn
Embecta: £150 Million Acquisition Of Owen Mumford To Expand Drug Delivery Platform Capabilities - Pulse 2.0
Embecta rallies after UK firm deal worth $200 million - MSN
Aug Gainers: What is the PEG ratio of Embecta Corp2026 Big Picture & AI Forecasted Stock Moves - baoquankhu1.vn
Embecta to Acquire Owen Mumford for Up to £150 Million, Expanding Drug-Delivery Device Portfolio and Global Medical Supplies Presence 123 - Minichart
Embecta to Acquire Owen Mumford in £150M Deal, Expanding Drug Delivery and Chronic Care Portfolio - Pharmacy Times
Embecta to Acquire Owen Mumford, Expanding Drug-Delivery Portfolio - tipranks.com
Embecta (NASDAQ: EMBC) to acquire Owen Mumford in up to £150m deal - Stock Titan
Embecta to acquire Owen Mumford for up to £150 million By Investing.com - Investing.com India
Embecta Corp. agreed to acquire Owen Mumford Holdings Limited from Mark Owen, Adam Mumford, Ellen Owen, Kim Priddis,Nancy Millington and others for approximately £150 million. - MarketScreener
EmbectaAn Interesting Deal At An Interesting Time (NASDAQ:EMBC) - Seeking Alpha
Embecta to buy auto-injector maker Owen Mumford for $200M to diversify beyond insulin - Fierce Biotech
Embecta to acquire auto-injector maker Owen Mumford for up to $199.4M - drugdeliverybusiness.com
Embecta to buy Owen Mumford for up to $201M - MedTech Dive
Embecta to acquire UK medical device maker Owen Mumford for $200M - NJBIZ
Embecta (NASDAQ:EMBC) Trading 4.5% HigherTime to Buy? - MarketBeat
Embecta to Acquire Owen Mumford for up to $199.4M - Medical Product Outsourcing
Embecta acquires Owen Mumford for £150M - BioWorld MedTech
Embecta’s $133M Acquisition of Owen Mumford Marks a Turning Point - Medical Device and Diagnostic industry
Embecta Rallies After UK Firm Deal Worth $200 Million - Benzinga
Embecta Corp (EMBC) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):